scholarly article | Q13442814 |
P50 | author | Jessica M S Jutzy | Q84757328 |
Nathan R. Wall | Q38324556 | ||
P2093 | author name string | William Langridge | |
Oludare Odumosu | |||
Kimberly Payne | |||
Ineavely Baez | |||
P2860 | cites work | Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes | Q80736018 |
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA | Q81487908 | ||
Expression of chemokine-like factor 1 is upregulated during T lymphocyte activation | Q82754186 | ||
A Toll-like receptor recognizes bacterial DNA | Q24290668 | ||
Toll-like receptor signalling | Q24570126 | ||
Surprising leads for a cholera toxin receptor-binding antagonist: crystallographic studies of CTB mutants | Q27732558 | ||
Crystal structure of a new heat-labile enterotoxin, LT-IIb | Q27733378 | ||
Toll-like receptors | Q27860671 | ||
Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions | Q28282106 | ||
Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes | Q28299458 | ||
Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6 | Q28646148 | ||
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes | Q29619621 | ||
Reciprocal control of T helper cell and dendritic cell differentiation | Q74452751 | ||
Toll-like receptors control activation of adaptive immune responses | Q74486847 | ||
Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells | Q77291206 | ||
The Th1/Th2 paradigm and allergic disorders | Q77591388 | ||
Th1 and Th2 cells | Q77922246 | ||
Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice | Q78402068 | ||
Interleukin-12 and tumour necrosis factor-alpha equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitus | Q80506814 | ||
Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes | Q80587031 | ||
Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice | Q30498716 | ||
[Detection of IFN-gamma level in single CD8+ T cell]. | Q33210532 | ||
Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large | Q33342232 | ||
Toll-like receptor 2 mediates cellular activation by the B subunits of type II heat-labile enterotoxins | Q33716162 | ||
Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes | Q33840423 | ||
The NOD mouse model of type 1 diabetes: as good as it gets? | Q33865111 | ||
Differentiation of T regulatory cells by immature dendritic cells | Q34157114 | ||
Type I diabetes mellitus. A chronic autoimmune disease | Q34181699 | ||
Targeting of cholera toxin and Escherichia coli heat labile toxin in polarized epithelia: role of COOH-terminal KDEL | Q34289590 | ||
Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. | Q34324135 | ||
Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patches | Q34521786 | ||
Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. | Q34674471 | ||
Recent advances in mucosal vaccines and adjuvants | Q34786990 | ||
Distinct dendritic cell subsets differentially regulate the class of immune response in vivo | Q34950113 | ||
Recognition of pathogen-associated molecular patterns by TLR family | Q35044748 | ||
Cholera holotoxin assembly requires a hydrophobic domain at the A-B5 interface: mutational analysis and development of an in vitro assembly system | Q35106484 | ||
Initial studies of the structural signal for extracellular transport of cholera toxin and other proteins recognized by Vibrio cholerae. | Q35445424 | ||
Dendritic-cell control of pathogen-driven T-cell polarization | Q35597117 | ||
Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent | Q35619878 | ||
Human CD(4+)CD(25+) regulatory T cells and infectious tolerance | Q35630656 | ||
Dendritic cell immunotherapy: mapping the way. | Q35762464 | ||
Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance | Q35878983 | ||
New insights into the molecular mechanism of interleukin-10-mediated immunosuppression | Q35937678 | ||
A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes | Q36140954 | ||
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus | Q36176985 | ||
Autoimmune destruction of pancreatic beta cells. | Q36310464 | ||
The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice | Q36367836 | ||
Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase | Q36370946 | ||
B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes | Q36437651 | ||
Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state | Q36459935 | ||
Targeting cytokines of the interleukin-12 family in autoimmunity | Q36486132 | ||
Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators. | Q36595292 | ||
TLR signaling pathways: opportunities for activation and blockade in pursuit of therapy | Q36651901 | ||
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists | Q36811131 | ||
What predicts mucosal inflammation in Crohn's disease patients? | Q36896566 | ||
Antigen-driven peripheral immune tolerance. Suppression of organ-specific autoimmune diseases by oral administration of autoantigens | Q36968782 | ||
Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo | Q37084615 | ||
IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow | Q37137338 | ||
Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit | Q37494112 | ||
Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin | Q37622936 | ||
Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells | Q39522002 | ||
Effect of insulin on functional status of cord blood-derived dendritic cells and on dendritic cell-induced CTL cytotoxicity against pancreatic cancer cell lines | Q39788361 | ||
Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation | Q39971245 | ||
Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens | Q40382880 | ||
The role of IL-12 in the induction of organ-specific autoimmune diseases | Q40404319 | ||
Recombinant cholera toxin B subunit activates dendritic cells and enhances antitumor immunity. | Q40467105 | ||
Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression | Q40493664 | ||
Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm | Q42035404 | ||
Oral administration of collagen conjugated with cholera toxin induces tolerance to type II collagen and suppresses chondritis in an animal model of autoimmune ear disease | Q43683297 | ||
Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation | Q44015062 | ||
B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice | Q44262351 | ||
Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitis | Q45889466 | ||
A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes | Q45889680 | ||
Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli | Q46052151 | ||
Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy | Q46155756 | ||
Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease | Q47346480 | ||
Multiple cytokine analysis in human tears: an optimized procedure for cytometric bead-based assay | Q47594873 | ||
Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. | Q47682161 | ||
Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. | Q51035411 | ||
Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. | Q53928842 | ||
[Influence of oral colonization with probiotic E. coli strain after birth on frequency of recurrent infections, allergy and development of some immunologic parameters. Long-term studies]. | Q54490397 | ||
Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope | Q59060541 | ||
Autocrine Production of IL-10 Mediates Defective IL-12 Production and NF- B Activation in Tumor-Associated Macrophages | Q59510838 | ||
Cholera Toxin Promotes the Induction of Regulatory T Cells Specific for Bystander Antigens by Modulating Dendritic Cell Activation | Q59632296 | ||
Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin Treatment | Q70311233 | ||
Insulin-dependent diabetes mellitus | Q71046915 | ||
Immunization With the Larger Isoform of Mouse Glutamic Acid Decarboxylase (GAD67) Prevents Autoimmune Diabetes in NOD Mice | Q71656099 | ||
Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4 | Q71828924 | ||
The pathogenesis of insulin-dependent diabetes mellitus | Q72827807 | ||
Effects of oral administration of type II collagen on rheumatoid arthritis | Q72936919 | ||
Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression | Q73010751 | ||
Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit | Q73022255 | ||
Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit | Q73066956 | ||
Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity | Q73691187 | ||
Mice resistant to experimental autoimmune encephalomyelitis have increased thymic expression of myelin basic protein and increased MBP specific T cell tolerance | Q73701505 | ||
Induction of tolerance by IL-10-treated dendritic cells | Q73873437 | ||
The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse | Q74371030 | ||
Efficacy of a food plant-based oral cholera toxin B subunit vaccine | Q74401546 | ||
P433 | issue | 4 | |
P921 | main subject | cholera | Q12090 |
dendritic cell | Q506253 | ||
P304 | page(s) | 447-456 | |
P577 | publication date | 2010-09-24 | |
P1433 | published in | Immunobiology | Q15754985 |
P1476 | title | Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit | |
P478 | volume | 216 |